- Counter Cyclical Investments’ high-risk, small-cap strategy has delivered outsized returns, making it a PMS chart topper
- This at a time of broader market volatility, when small-caps were being particularly hammered
- The firm’s diversified portfolio spread across 100–130 stocks makes it less vulnerable to market risks
- Its penchant for deep research, not to mention its many quirks, make it stand out among peers
Enter your email address to receive a daily summary of all our stories.
“Don’t disturb us by calling for reassurance every time the market falls.”
This is just one of several disclaimers spattered across the website of Counter Cyclical Investments. It’s a six-year-old portfolio management service (PMS) firm based in Nagpur. Not Mumbai. Not Bengaluru. Nagpur—a tier-2 city in Maharashtra.
Counter Cyclical doesn’t do handholding. What it does do is continue to bet on small-cap stocks amid the broader market turmoil. And also come out as the top performer among all PMS firms for which data is available, offering 78% annualised returns on a five-year basis as of March. For perspective, if one had invested Rs 10,000 ($116) back then, they would be sitting on about Rs 1.8 lakh ($2,000) now.
This, when the call for exiting high-risk small- and mid-cap stocks had been growing louder since September, reaching a crescendo with ICICI Prudential’s chief investment officer
Expectedly, some small-cap-focused PMS firms, including
But not Keshav Garg, founder and director of Counter Cyclical. Rather than take any cash calls, Garg returned Rs 200 crore (or 25% of the firm’s assets under management (AUM)) to investors. He also stopped accepting fresh money from June onwards as he was “just not able to find value”.
“At the time, we faced huge resistance because everybody wanted to put more money in the markets,” recalled Garg. The firm finally reopened to new capital, with the same old playbook: deep research to find and invest in small-cap, even nano-cap stocks since—as its website makes clear—“no company is too small”.
Share this article with your network
Send the article link to friends or colleagues who might find this story interesting or insightful.
Send the article link to friends or colleagues who might find this story interesting or insightful.